EDRH
CAI

Edmond de Rothschild Holding’s Caris Life Sciences CAI Stock Holding History

Edmond de Rothschild Holding’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$498K Buy
27,965
+5,350
+24% +$95.8K 0.01% 375
2026
Q1 		$404K Buy
22,615
+10,350
+84% +$226K 0.01% 336
2025
Q4 		$331K Buy
12,265
+4,765
+64% +$134K ﹤0.01% 355
2025
Q3 		$227K Buy
+7,500
New +$239K ﹤0.01% 381

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Edmond de Rothschild Holding's CAI Position: Q2 2026 in Review

Edmond de Rothschild Holding increased its Caris Life Sciences (CAI) stake by 24% in Q2 2026, buying an estimated $95.8K and bringing the position to 27,965 shares worth $498K. The position accounts for 0.01% of the portfolio, ranked #375.

Edmond de Rothschild Holding first reported a position in CAI in Q3 2025 and has held it in 4 quarters since. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Edmond de Rothschild Holding held 27,965 shares of Caris Life Sciences worth $498K as of Q2 2026.
  • Edmond de Rothschild Holding bought 5,350 Caris Life Sciences shares in Q2 2026, an estimated $95.8K.
  • Caris Life Sciences made up 0.01% of Edmond de Rothschild Holding's portfolio in Q2 2026, its #375 holding.
  • Edmond de Rothschild Holding first reported a position in Caris Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2026, filed 10 Aug 2026.